Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Alba Parra-Martínez et al.|Science Immunology|2021Cited by 638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Proceedings of the National Academy of Sciences|2022Cited by 198
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Research Square|2022Cited by 24
Genetic regulation of <i>OAS1</i> nonsense-mediated decay underlies association with risk of severe COVID-19Abdul Rouf Banday, Yu Zhang, Megan L. Stanifer et al.|medRxiv|2021Cited by 13
Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Adrian Gervais et al.|Science Immunology|2021Cited by 1